secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stemtech Corp (STEK)
CIK:        0001511820
Form:       8-K
Filed at:   2024-12-06T23:59:59+00:00
Accession:  0001683168-24-008550
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stemtech signs LOI for reverse takeover of Eevia Health and merger with Viago; aims for 85% stake in Eevia
--------------------------------------------------------------------------------

- Non-binding LOI for RTO: Stemtech/Viago to acquire Eevia Health (Swedish-listed) by issuing shares; Stemtech to own ~85% of combined entity.
- Merger agreement with Seacret Direct/Viago: Stemtech to issue 13M preferred shares (stated value $2.50) convertible into 50% of fully diluted common stock.
- Combined entity expects to double Stemtech revenue in 2025 through cost synergies and expanded product portfolio.
- Viago/Stemtech operates in 40+ countries with 250,000+ members; Eevia has production facility in Finland.
- Closing conditions include audit of Viago, stockholder approvals, and negotiation of definitive agreements; if not closed by June 25, 2025, can terminate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1511820/000168316824008550/0001683168-24-008550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1511820/000168316824008550/stemtech_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-008550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer